0
Détail de l'éditeur
European Respiratory Society (ERS)
Collections rattachées :
|
Documents disponibles chez cet éditeur (31)
Ajouter le résultat dans votre panier Affiner la recherche
Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD / J-Q. He (2008)
Titre : Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD Type de document : texte imprimé Auteurs : J-Q. He, Auteur ; K. Shumansky, Auteur ; J.E. Connett, Auteur ; N.R. Anthonisen, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2008 Collection : European Respiratory Journal num. 32 Importance : p. 25-34 Présentation : tab., graph. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] tabagisme:pathologie:pathologie respiratoire:broncho-pneumopathie chronique obstructive
[TABAC] tabagisme:risque:facteur associé:génétiqueIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Granulocyte-macrophage colony-stimulating factor (CSF), also known as CSF2, and granulocyte CSF, also known as CSF3, are important survival and proliferation factors for neutrophils and macrophages. The objective of the present study was to determine whether single nucleotide polymorphisms (SNPs) of CSF2 and CSF3 are associated with lung function in smoking-induced chronic obstructive pulmonary disease. In total, five SNPs of CSF2 and CSF3 were studied in 587 non-Hispanic white subjects with the fastest (n = 281) or the slowest (n = 306) decline of lung function selected from among continuous smokers in the National Heart, Lung, and Blood Institute Lung Health Study (LHS). These SNPs were also studied in 1,074 non-Hispanic white subjects with the lowest (n = 536) or the highest (n = 538) baseline lung function at the beginning of the LHS. An increase in the number of CSF3 -1719T alleles was significantly associated with protection against low lung function (odds ratio 0.73, 95% confidence interval 0.56-0.95), and was still significant after adjustment for multiple comparisons. There was also a significant association of a CSF3 haplotype with baseline levels of forced expiratory volume in one second. No association was found for CSF2 SNPs and lung function, nor was there evidence of epistasis. In conclusion, genetic variation in colony-stimulating factor 3 is associated with cross-sectionally measured lung function in smokers. En ligne : https://erj.ersjournals.com/content/32/1/25.long Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8069 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Asthma in the elderly : a different disease ? Type de document : document électronique Auteurs : Salvatore Battaglia, Auteur ; Alida Benfante, Auteur ; Mario Spatafora, Auteur ; Nicola Scichilone, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : Breathe, ISSN 1810-6838 num. 12 Importance : p.18-28 Langues : Anglais (eng) Catégories : [DIVERS] personne:par âge:senior
[PROMOSAN] asthme
[TABAC] tabagisme:pathologie:pathologie respiratoire:asthmeIndex. décimale : AA 1.1. Généralités En ligne : https://doi.org/10.1183/20734735.002816 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9435 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Bedaquiline in the treatment of multidrug- and extensively drugresistant tuberculosis / Alexander S. Pym (2016)
Titre : Bedaquiline in the treatment of multidrug- and extensively drugresistant tuberculosis Type de document : document électronique Auteurs : Alexander S. Pym, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47 Importance : p.564-574 Langues : Anglais (eng) Catégories : [TUBER] traitement:traitement curatif:médicament spécial MDR:bédaquiline Index. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) En ligne : https://doi.org/10.1183/13993003.00724-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9430 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Benefit of treatment of latent tuberculosis infection in individual patients / Claudia C. Dobler (2015)
Titre : Benefit of treatment of latent tuberculosis infection in individual patients Type de document : document électronique Auteurs : Claudia C. Dobler, Auteur ; Andrew Martin, Auteur ; Guy B. Marks, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. 46(5) Importance : p.1397-1406 Présentation : ill. ; tab. ; graph. Langues : Anglais (eng) Catégories : [TUBER] traitement:traitement préventif
[TUBER] type de tuberculose:infection tuberculeuse latenteIndex. décimale : TU 8.5. Traitement spécifique En ligne : https://doi.org/10.1183/13993003.00577-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9415 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Cigarette smoke enhances {beta}-defensin 2 expression in rat airways via nuclear factor-{kappa}B activation / L. Chen (2010)
Titre : Cigarette smoke enhances {beta}-defensin 2 expression in rat airways via nuclear factor-{kappa}B activation Type de document : texte imprimé Auteurs : L. Chen, Auteur ; P.P. Sun, Auteur ; T. Wang, Auteur ; X. Wang, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 36 Importance : p.638-645 Présentation : graph., ill. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] étude
[TABAC] tabagisme:pathologie:pathologie respiratoire:broncho-pneumopathie chronique obstructiveIndex. décimale : TA 3.2.2.1 Expérimentation Résumé : β-defensin 2 (BD-2), an antimicrobial peptide, participates in airway defence. Cigarette smoke (CS) is a major risk factor for the development of chronic obstructive pulmonary disease. This study mainly aims to investigate the effect of CS on rat BD-2 (rBD-2) expression in rat airways. Rats were exposed to CS and treated with caffeic acid phenethyl ester (CAPE), a nuclear factor (NF)-κB inhibitor, or astragaloside IV (AS-IV), an active ingredient of Astragalus mongholicus. Besides the analysis of bronchoalveolar lavage fluid (BALF) and histological changes after CS exposure, rBD-2 expression was investigated with immunohistochemistry, reverse transcription PCR and ELISA. Total glutathione and nitric oxide (NO) levels in rat lungs were also detected. CS exposure markedly increased rBD-2 immunoreactivity, as well as rBD-2 mRNA and protein levels in rat airways, which were inhibited by CAPE treatment. Moreover, associated airway inflammation induced by CS was demonstrated by histological changes, increased cell counts and pro-inflammatory cytokines in BALF, and NF-κB activation and high levels of total glutathione and NO, which were all reversed by AS-IV in a dose-dependent fashion. In conclusion, CS exposure induces rBD-2 expression in rat airways via a NF-κB-dependent pathway, and AS-IV attenuates CS-induced airway inflammation due to its anti-inflammatory and antioxidant properties, at least partly through NF-κB inactivation. En ligne : https://erj.ersjournals.com/content/36/3/638.long Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8075 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Cigarette smoke extract reduces VEGF in primary human airway epithelial cells / J.V. Thaikoottathil (2009)
Titre : Cigarette smoke extract reduces VEGF in primary human airway epithelial cells Type de document : texte imprimé Auteurs : J.V. Thaikoottathil, Auteur ; R.J. Martin, Auteur ; J. Zdunek, Auteur ; A. Weinberger, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 33:4 Importance : p.835-843 Présentation : tab., tab., ill. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] tabagisme:effet du tabac:effet sur l'immunitéIndex. décimale : TA 3.2.2.2.1 Interactions avec d'autres facteurs pathogènes Résumé : Reduced vascular endothelial growth factor (VEGF) has been reported in bronchoalveolar lavage fluid and lungs of severe emphysema patients. Airway epithelial cells (AEC) are exposed to various environmental insults like cigarette smoke and bacterial infections, but their direct effect on VEGF production in well-differentiated primary human AEC remains unclear. The current authors determined the effect of cigarette smoke extract (CSE) alone and in combination with Mycoplasma pneumoniae (Mp) on VEGF production in well-differentiated primary normal human bronchial epithelial (NHBE) and small airway epithelial cells (SAEC) in air-liquid interface cultures. Secretion and expression of VEGF were determined by ELISA and real-time RT-PCR, respectively. Cell growth, apoptosis, extracellular signal-regulated kinase (ERK)1/2 and protein kinase (PK)C signalling pathways were evaluated to further dissect VEGF regulation under CSE treatment. CSE significantly reduced VEGF secretion in NHBE and SAEC. In SAEC, Mp alone significantly increased the VEGF, while the presence of CSE attenuated Mp-induced VEGF production. While ERK inhibitor reduced VEGF secretion only in NHBE, a PKC inhibitor significantly decreased VEGF secretion in both NHBE and SAEC. In conclusion, direct cigarette smoke extract exposure significantly reduced vascular endothelial growth factor production in well-differentiated primary human airway epithelial cells, in part through modifying extracellular signal-regulated kinase 1/2 and protein kinase C signalling pathways. En ligne : https://erj.ersjournals.com/content/33/4/835.long Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8063 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor / E. Mortaz (2010)
Titre : Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor Type de document : texte imprimé Auteurs : E. Mortaz, Auteur ; I.M. Adcock, Auteur ; K. Ito, Auteur ; A.D. Kraneveld, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 36 Importance : p. 1143-1154 Présentation : graph. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] étude
[TABAC] tabagisme:effet du tabac:effet sur l'immunité
[TABAC] tabagisme:pathologie:pathologie respiratoire:broncho-pneumopathie chronique obstructiveIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Chronic obstructive pulmonary disease (COPD) is a major health problem and cigarette smoke is the main risk factor for the development of COPD. The characteristic changes in airway morphology, inflammatory cell infiltration and mediator expression in COPD may result from direct effects of cigarette smoke on airway cells. Toll-like receptors (TLRs) are key elements in pathogen recognition by the host immune system. Although TLRs have been intensely studied in innate immunity and infection, their critical role in noninfectious challenges has only recently emerged. Here we investigate whether cigarette smoke induces TLR9 signalling in human neutrophils. Human neutrophils were isolated from buffy coat and exposed to cigarette smoke extract. The production of CXC chemokine ligand (CXCL)8 was measured as a functional readout and the role of TLR9 signalling was investigated. Cigarette smoke extract induced CXCL8 release via TLR9 activation in neutrophils, which was confirmed in TLR9 stably transfected human embryonic kidney 293 cells. Moreover, cigarette smoke extract upregulated the expression of TLR9 and the upregulated expression was suppressed by N-acetylcysteine. TLR9 mediates cigarette smoke-induced release of CXCL8 and this may contribute to the accumulation of neutrophils and inflammation within the airways of smokers. En ligne : https://erj.ersjournals.com/content/36/5/1143 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8071 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005622 TA 3.2.2.4 MOR C Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals / Roland Diel (2016)
Titre : Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Type de document : document électronique Auteurs : Roland Diel, Auteur ; Albert Nienhaus, Auteur ; Doris Hillemann, Auteur ; Elvira Richter, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47 Importance : p.575-587 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Allemagne
[TUBER] diagnostic
[TUBER] traitement:résistance:multirésistance
[TUBER] traitement:structure:hôpitalIndex. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) En ligne : https://doi.org/10.1183/13993003.00811-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9429 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany / Lara J. Wolfson (2015)
Titre : Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany Type de document : document électronique Auteurs : Lara J. Wolfson, Auteur ; Judith Gibbert, Auteur ; Roland Diel, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. 46 Importance : p.1826-1829 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Allemagne
[TUBER] traitement:traitement curatif:médicament spécial MDR:bédaquilineIndex. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) En ligne : https://doi.org/10.1183/13993003.00811-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9422 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Costs of tuberculosis disease in the European Union : a systematic analysis and cost calculation Type de document : document électronique Auteurs : Roland Diel, Auteur ; Joris Vandeputte, Auteur ; Gerard de Vries, Auteur ; Jonathan Stillo, Auteur ; Maryse Wanlin (1954 - ...), Auteur ; Albert Nienhaus, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2014 Collection : European Respiratory Journal num. 43 Importance : p.554-565 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe
[PROMOSAN] prévention:santé:coût de la santé
[TUBER] prévention:stratégieIndex. décimale : TU 3.1. Généralités En ligne : https://doi.org/10.1183/09031936.00079413 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9389 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Diagnostics for latent TB infection : incremental, not transformative progress Type de document : document électronique Auteurs : Madhukar Pai, Auteur ; Giovanni Sotgiu, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47 Importance : p.704-706 Langues : Anglais (eng) Catégories : [TUBER] diagnostic
[TUBER] type de tuberculose:infection tuberculeuse latenteIndex. décimale : TU 5. Méthodes de diagnostic En ligne : https://doi.org/10.1183/13993003.01910-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9432 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test / Michele Spinicci (2015)
Titre : Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test : need for a further step ? Type de document : document électronique Auteurs : Michele Spinicci, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. Vol 46 Issue 5 Importance : p.1506-1509 Présentation : tab. Langues : Anglais (eng) Catégories : [TUBER] diagnostic:test immunologique
[TUBER] étudeIndex. décimale : TU 6.2. IGRA En ligne : https://doi.org/10.1183/13993003.00403-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9413 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Does cannabis use predispose to chronic airflow obstruction ? Type de document : texte imprimé Auteurs : D.P. Tashkin, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 35 (1) Importance : p.3-5 Langues : Anglais (eng) Catégories : [TABAC] tabagisme:pathologie:pathologie respiratoire
[TABAC] tabagisme:risque:facteur associé:drogue:cannabisIndex. décimale : TA 1.1.5 Cannabis Résumé : Correspondance En ligne : https://erj.ersjournals.com/content/35/1/3 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2707 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Effect of low-dose thephylline plus beclometasone on lung function in smokers with asthma / M. Spears (2009)
Titre : Effect of low-dose thephylline plus beclometasone on lung function in smokers with asthma : a pilot stydy Type de document : texte imprimé Auteurs : M. Spears, Auteur ; I. Donnelly, Auteur ; M. Brannigan, Auteur ; K. Ito, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 33 suppl. Importance : p. 1010-1017 Présentation : tab., graph. Langues : Anglais (eng) Catégories : [PROMOSAN] asthme:traitement de l'asthme
[TABAC] étude
[TABAC] tabagisme:pathologie:pathologie respiratoire:asthmeIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Smoking is common in asthma and is associated with worse asthma control and a reduced therapeutic response to corticosteroids. The present authors hypothesised that treating smokers with asthma with low-dose theophylline added to inhaled corticosteroids would enhance steroid sensitivity and thereby improve lung function and symptoms. In a double-blind, parallel group exploratory trial, 68 asthmatic smokers were randomised to one of three treatments for 4 weeks: inhaled beclometasone (200 microg day(-1)), theophylline (400 mg day(-1)) or both treatments combined. Outcome measures included change in lung function and Asthma Control Questionnaire (ACQ) scores. At 4 weeks, theophylline added to inhaled beclometasone produced an improvement in peak expiratory flow (39.9 L min(-1), 95% confidence intervals (CI) 10.9-68.8) and ACQ score (-0.47, 95% CI -0.91- -0.04) and a borderline improvement in pre-bronchodilator forced expiratory volume in one second (mean difference 165 mL, 95% CI -13-342) relative to inhaled corticosteroid alone. Theophylline alone improved the ACQ score (-0.55, 95% CI -0.99- -0.11), but not lung function. In the present pilot study, the combination of low-dose theophylline and inhaled beclometasone produced improvements in both lung function and symptoms in a group of smokers with asthma. Larger trials are required to extend and confirm these findings. En ligne : https://erj.ersjournals.com/content/33/5/1010 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8065 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Effectiveness and safety of meropenem / clavulanate-containing regimens in the treatment of MDR- and XDR-TB / Simon Tiberi (2016)
Titre : Effectiveness and safety of meropenem / clavulanate-containing regimens in the treatment of MDR- and XDR-TB Type de document : document électronique Auteurs : Simon Tiberi, Auteur ; Marie-Christine Payen, Auteur ; Giovanni Sotgiu, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. vol.47 nr 4 Importance : p.1235-1243 Langues : Anglais (eng) Catégories : [TUBER] étude
[TUBER] traitement:résistanceIndex. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) Résumé : No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate to treat multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB). The aim of this observational study was to evaluate the therapeutic contribution, effectiveness, safety and tolerability profile of meropenem/clavulanate added to a background regimen when treating MDR- and XDR-TB cases.
Patients treated with a meropenem/clavulanate-containing regimen (n=96) showed a greater drug resistance profile than those exposed to a meropenem/clavulanate-sparing regimen (n=168): in the former group XDR-TB was more frequent (49% versus 6.0%, p<0.0001) and the median (interquartile range (IQR)) number of antibiotic resistances was higher (8 (6–9) versus 5 (4–6)). Patients were treated with a meropenem/clavulanate-containing regimen for a median (IQR) of 85 (49–156) days.
No statistically significant differences were observed in the overall MDR-TB cohort and in the subgroups with and without the XDR-TB patients; in particular, sputum smear and culture conversion rates were similar in XDR-TB patients exposed to meropenem/clavulanate-containing regimens (88.0% versus 100.0%, p=1.00 and 88.0% versus 100.0%, p=1.00, respectively). Only six cases reported adverse events attributable to meropenem/clavulanate (four of them then restarting treatment).
The nondifferent outcomes and bacteriological conversion rate observed in cases who were more severe than controls might imply that meropenem/clavulanate could be active in treating MDR- and XDR-TB cases.En ligne : https://doi.org/10.1183/13993003.02146-2015 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10150 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of cannabis on lung function : a population-based cohort study Type de document : texte imprimé Auteurs : R.J. Hancox, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 35 (1) Importance : p. 42-47 Langues : Anglais (eng) Catégories : [DIVERS] anatomie:corps humain:appareil respiratoire
[TABAC] étude
[TABAC] tabagisme:risque:facteur associé:drogue:cannabis
[TABAC] tabagisme:tabagisme actifIndex. décimale : TA 1.1.5 Cannabis Résumé : The effects of cannabis on lung function remain unclear and may be different from those of tobacco. We compared the associations between use of these substances and lung function in a population-based cohort (n = 1,037). Cannabis and tobacco use were reported at ages 18, 21, 26 and 32 yrs. Spirometry, plethysmography and carbon monoxide transfer factor were measured at 32 yrs. Associations between lung function and exposure to each substance were adjusted for exposure to the other substance. Cumulative cannabis use was associated with higher forced vital capacity, total lung capacity, functional residual capacity and residual volume. Cannabis was also associated with higher airway resistance but not with forced expiratory volume in 1 s, forced expiratory ratio or transfer factor. These findings were similar among those who did not smoke tobacco. In contrast, tobacco use was associated with lower forced expiratory volume in 1 s, lower forced expiratory ratio, lower transfer factor and higher static lung volumes, but not with airway resistance. Cannabis appears to have different effects on lung function from those of tobacco. Cannabis use was associated with higher lung volumes, suggesting hyperinflation and increased large-airways resistance, but there was little evidence for airflow obstruction or impairment of gas transfer. En ligne : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805041/ Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2706 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment / Nicholas Winters (2015)
Titre : Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment Type de document : document électronique Auteurs : Nicholas Winters, Auteur ; Guillaume Butler-Laporte, Auteur ; Dick Menzies, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. 46 Importance : p.1461-1470 Langues : Anglais (eng) Catégories : [TUBER] traitement:résistance:multirésistance
[TUBER] traitement:traitement curatif:médicament spécial MDRIndex. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) En ligne : https://erj.ersjournals.com/content/46/5/1461 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9418 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Electronic cigarette marketing and smoking behaviour in adolescence : a cross-sectional study Type de document : texte imprimé Auteurs : Julia Hansen, Auteur ; Reiner Hanewinkel, Auteur ; Matthis Morgenstern, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2018-09-08 Collection : Breathe, ISSN 1810-6838 Importance : 10 p. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Allemagne
[DIVERS] personne:famille:adolescent
[TABAC] économie du tabac:marketing:publicité
[TABAC] étudeIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) En ligne : https://openres.ersjournals.com/content/4/4/00155-2018 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8974 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 006881 TA 1.1.1 HAN E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Electronic cigarette use in youths : a position statement of the Forum of International Respiratory Societies Type de document : document électronique Auteurs : Thomas W. Ferkol, Auteur ; Harold J. Farber, Auteur ; Stefania La Grutta, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2018 Collection : European Respiratory Journal Importance : 9 p. Langues : Anglais (eng) Catégories : [DIVERS] personne:famille:adolescent
[DIVERS] personne:famille:enfant
[TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] prévention:recommandation
[TABAC] tabagisme:effet du tabac:effet neurologiqueIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Children and adolescents are highly susceptible to nicotine addiction, which affects their brain development, even in those who smoke infrequently. Young people who become addicted to nicotine are at greater risk of becoming lifelong tobacco consumers. The use of nicotine-delivering electronic cigarettes has risen dramatically among youths worldwide. In addition to physical dependence, adolescents are susceptible to social and environmental influences to use electronic cigarettes. The product design, flavours, marketing, and perception of safety and acceptability have increased the appeal of electronic cigarettes to young people, thus leading to new generations addicted to nicotine. Moreover, there is growing evidence that electronic cigarettes in children and adolescents serve as a gateway to cigarette
smoking. There can be no argument for harm reduction in children. To protect this vulnerable population from electronic cigarettes and other nicotine delivery devices, we recommend that electronic cigarettes be regulated as tobacco products and included in smoke-free policies. Sale of electronic cigarettes should be
barred to youths worldwide. Flavouring should be prohibited in electronic cigarettes, and advertising accessible by youths and young adults be banned. Finally, we recommend greater research on the health effects of electronic cigarettes and surveillance of use across different countries.En ligne : https://doi.org/10.1183/13993003.00278-2018 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9737 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
ERS Position Paper on Tobacco Harm Reduction / Comité de contrôle du tabagisme de l’European Respiratory Society (ERS) et (2019)
Titre : ERS Position Paper on Tobacco Harm Reduction Type de document : document électronique Auteurs : Comité de contrôle du tabagisme de l’European Respiratory Society (ERS) et, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2019 Importance : 19 p. Langues : Anglais (eng) Catégories : [TABAC] prévention:stratégie:réduction du risque
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotiniqueIndex. décimale : TA 5.8 Réduction des risques Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9741 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and “harm reduction” / Daniel Tzu-Hsuan Chen (2024)
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Exposure to second-hand smoke / M. Pérez-Rios (2007)
Titre : Exposure to second-hand smoke : a population-based survey in Spain Type de document : texte imprimé Auteurs : M. Pérez-Rios, Auteur ; M.I. Santiago-Pérez, Auteur ; B. Alonso, Auteur ; A. Malvar, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2007 Collection : European Respiratory Journal num. 29:4 Importance : p. 818-819 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe méridionale:Espagne
[TABAC] étude:enquête
[TABAC] tabagisme:tabagisme passif:tabagisme environnementalIndex. décimale : TA 7.1 Généralités Résumé : Between December 2004 and January 2005, we developed a study on tobacco use and SHS exposure among the general population in the northern Spanish region of Galicia. The source of sampling was the regional healthcare card system, which covers 97% of the population. The study yielded SHS exposure data collected in Galicia, based on a representative population sample. Galicia is located in the north-west of Spain and was estimated to have a population of 2.7 million in 2004, with a smoking prevalence of 29% (95% confidence interval 27.8–30.2%). People who smoked daily or occasionally were classified as smokers. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8114 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005671 TA 7.1 PER E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Genetic variation as a predictor of smoking cessation. A promising preventive and intervention tool for chronic respiratory diseases / M. Quaak (2009)
Titre : Genetic variation as a predictor of smoking cessation. A promising preventive and intervention tool for chronic respiratory diseases Type de document : texte imprimé Auteurs : M. Quaak, Auteur ; C.P. van Schayck, Auteur ; A.M. Knaapen, Auteur ; F.J. van Schooten, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 33 Importance : p. 468-480 Présentation : tab., ill. Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique
[TABAC] tabagisme:aspect psychologique:comportement:addiction:traitement des addictions
[TABAC] tabagisme:risque:facteur associé:génétiqueIndex. décimale : TA 4.1.1 Facteurs prédictifs du tabagisme (génétique inclus) Résumé : obacco smoking continues to be the largest preventable cause of premature morbidity and mortality throughout the world, including chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease. Although most smokers are highly motivated to quit and many smoking cessation therapies are available, cessation rates remain very low.
Recent research strongly suggests that variation in genetic background is an important determinant of smoking behaviour and addiction. Since these genetic variants might also influence the response to smoking cessation pharmacotherapies, it is likely that assessment of genetic background could be a promising tool to guide selection of the most effective cessation treatment for an individual smoker. Recently, it has been shown that genetic variants in the dopaminergic system, opioid receptors, the bupropion-metabolising enzyme CYP2B6 and the nicotine-metabolising enzyme CYP2A6 may play an important role in predicting smoking cessation responses to nicotine replacement therapy and bupropion treatment. Despite the progress that has been made, several challenges will still have to be overcome before genetically tailored smoking cessation therapy can be implemented in standard clinical practice.En ligne : https://erj.ersjournals.com/content/33/3/468 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8070 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic / J.E. Heck (2010)
Titre : Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic Type de document : texte imprimé Auteurs : J.E. Heck, Auteur ; I. Stücker, Auteur ; Shane Allwright, Auteur ; E.R. Gritz, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 35:5 Importance : p. 969-979 Présentation : tab., graph. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe du Nord:Suède
[DIVERS] géographie:Europe:Europe méridionale:Italie
[DIVERS] géographie:Europe:Europe occidentale:France
[DIVERS] géographie:Europe:Europe occidentale:Irlande
[DIVERS] personne:par sexe:femme:femme enceinte
[PROMOSAN] allergie:type d'allergie:allergie environnementale:habitation
[TABAC] étude
[TABAC] législation:législation antitabac:interdiction de fumer
[TABAC] législation:milieu réglementé:lieu de travail
[TABAC] tabagisme:tabagisme passifMots-clés : Tchéquie ou République tchèque Index. décimale : TA 9.3 Législation européenne et mondiale Résumé : The purpose of this study was to report predictors and prevalence of home and workplace smoking bans in five European countries. We conducted a population-based telephone survey of 4,977 females, ascertaining factors associated with smoking bans. Odds ratios and 95% confidence intervals were derived using unconditional logistic regression. A complete home smoking ban was reported by 59.5% of French, 63.5% of Irish, 61.3% of Italian, 74.4% of Czech and 87.0% of Swedish females. Home smoking bans were associated with younger age and being bothered by secondhand smoke, and among smokers, inversely associated with greater tobacco dependence. Among nonsmokers, bans were also related to believing smoking is harmful (OR 1.20, 95% CI 1.11-1.30) and having parents who smoke (OR 0.62, 95% CI 0.52-0.73). Workplace bans were reported by 92.6% of French, 96.5% of Irish, 77.9% of Italian, 79.1% of Czech and 88.1% of Swedish females. Workplace smoking bans were reported less often among those in technical positions (OR 0.64, 95% CI 0.50-0.82) and among skilled workers (OR 0.53, 95% CI 0.32-0.88) than among professional workers. Workplace smoking bans are in place for most workers in these countries. Having a home smoking ban was based on smoking behaviour, demographics, beliefs and personal preference. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8104 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005652 TA 9.3 HEC H Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space / P. Glader (2008)
Titre : Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Type de document : texte imprimé Auteurs : P. Glader, Auteur ; B. Eldh, Auteur ; S. Bozinovski, Auteur ; K. Andelid, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2008 Collection : European Respiratory Journal num. 32 Importance : p.644-650 Présentation : tab., ill. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] étude
[TABAC] tabagisme:effet du tabac
[TABAC] tabagisme:pathologie:pathologie respiratoire:broncho-pneumopathie chronique obstructiveIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Clinical studies have indicated increased gelatinase activity in the airways of patients suffering from chronic obstructive pulmonary disease caused by tobacco smoke. The present study aimed to determine whether acute exposure to tobacco smoke per se causes a substantial and lasting impact on gelatinases and their inhibitors in the peripheral airways of atopic and nonatopic human subjects.
Bronchoscopy with bronchoalveolar lavage (BAL) was performed on occasional smokers with and without atopy before and after smoking 10 cigarettes over a 48-h period. Samples from a group of never-smokers not exposed to tobacco smoke served as controls. Gelatinase identity and activity were measured using zymography, and gelatinase activity assay and concentrations of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 were measured using ELISA.
The results revealed no pronounced changes in identity, net activity or concentration of the gelatinases or changes in concentrations of TIMP-1 and TIMP-2 in BAL fluid before and after acute exposure to tobacco smoke.
In conclusion, the present experimental study indicates that acute exposure to tobacco smoke does not cause any substantial impact on gelatinases or their inhibitors in the peripheral airways, irrespective of atopy status, a finding that is compatible with the fact that it takes many years of tobacco smoking to establish chronic obstructive pulmonary disease.En ligne : https://erj.ersjournals.com/content/32/3/644 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8073 Aucun avis, veuillez vous identifier pour ajouter le vôtre !